Linglong Deng, Hannah Petrek, Mei-Juan Tu, Neelu Batra, Ai-Xi Yu, & Ai-Ming Yu. (2023). Author correction to 'Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo' [Acta Pharmaceutica Sinica B 11 (2021) 3950-3965]. Elsevier.
Chicago Style (17th ed.) CitationLinglong Deng, Hannah Petrek, Mei-Juan Tu, Neelu Batra, Ai-Xi Yu, and Ai-Ming Yu. Author Correction to 'Bioengineered MiR-124-3p Prodrug Selectively Alters the Proteome of Human Carcinoma Cells to Control Multiple Cellular Components and Lung Metastasis In vivo' [Acta Pharmaceutica Sinica B 11 (2021) 3950-3965]. Elsevier, 2023.
MLA (9th ed.) CitationLinglong Deng, et al. Author Correction to 'Bioengineered MiR-124-3p Prodrug Selectively Alters the Proteome of Human Carcinoma Cells to Control Multiple Cellular Components and Lung Metastasis In vivo' [Acta Pharmaceutica Sinica B 11 (2021) 3950-3965]. Elsevier, 2023.